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Our study provides evidence for the existence of an acylhydrolasc activity in Tehd~ymerra pyrijormis cells, capable of hydrolizing the m-2 ester 
bond of the PAF molecule. This activity is mainly distributed in the microsomal fraction (76.5% of total) and has properties similar to the mamma- 
lian PAF-acetylhydrolase since it is Ca* “-independ cnt, acid-labile, is inhibited by DFP and PMSF but it is not affected by egg yolk phosphatidylcho- 
line. This microsomal acylhydrolase has apparent K,,, and V,,,, values of 1.56 PM and 373 pmols - mg * min respectively. This is the first report 
of the existence of a PAF-acetylhydrolase activity in a non-mammalian cell. 
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1. INTRODUCTION 
Platelet Activating Factor (PAF) identified as l-0 
alkyl-2-acetyl-sn-glycero-3-phosphocholine [l-3], is 
one of the most potent mediators in inflammatory and 
allergic reactions. PAF is synthesized and released by a 
variety of cells and tissues and displays an impressive 
spectrum of biological actions in vivo and in vitro (see 
reviews [4,5]). 
The intracellular or extracellular PAF levels are 
mainly regulated by a specific hydrolase which degrades 
PAF into the biologically inactive metabolite lyso-PAF, 
removing the acetyl group from the sn-2 position. This 
enzyme named as PAF-acetylhydrolase (PAF-AH) (EC 
3.1.1.48), is an acid-labile enzyme with properties 
distinct from the classic phospholipase AZ (PLA2) and 
is present in a variety of mammalian cells and tissues as 
well as in plasma and serum [6-l 11. 
Studies in our laboratory have shown that PAF is a 
minor lipid component in Terrahymena pyriformis 
cells, this being the first report for the natural occurence 
of PAF in a non-mammalian cell [12]. Moreover, ex- 
ogenously added PAF is taken up rapidly by T. pyrifor- 
rt~is and stimulates Ca2’ influx into the cells [13,14]. 
Recently we have shown that the intact cells of this pro- 
tozoan can rapidly metabolize xogenous PAF to 1-O 
~1 Ir/nwin/iorrs. PAF, pl;ltclct-ectivatilig factor; PAF-AH, PAF- 
acctylhydr0l;tsc; PLAi, phospholip;~sc AI; [“I-I]PAI‘, I-O-I~CKIJC~~I- 
2-[“IIJitcct~l-rn-glyccro-3.pliosphochalirie; (~H]illkyl.P/w, I-U- 
[I ‘.2’-‘l-l]llcxndCcyl-2-itcCtyl-5~l-~lycCr0-3-~~~i0stl~i0c~i0li~iC; IF%, 
bovine serum albumin; TCA, trichloroacctic acid; DW, diisopropyl- 
fluorophosphntc: IWSI~, phcnyln~cthyl~ulfon)‘lnuoridc. 
Cmqmtrlorcc ac/drm: A.D. Tsclcpis, Laboratory of l~iochcmintry, 
I~cpartnicw of Chcntiwy, Univcrrity of loannina, loanninit JS I 10, 
GiCCCC. 
alkyl-2-acyl(long chain)-sn-glycero-3_phosphocholine, 
suggesting a PAF deacetylation reaction as the in- 
termediate step in this metabolic route [lS]. In the pre- 
sent study we describe the existence of an acylhydrolase 
activity in T. pyriformis capable of hydrolyzing the sn-2 
acetyl moiety of PAF. The properties of this enzyme, 
similar to those of mammalian PAF-AH, are also 
discussed. 
2. EXPERKMENTAL 
2. I . Materials 
Diisopropylfluorophosphate (DFP), phenylmethylsulfonylfluoride 
(PMSF), essentially fatty acid-free bovine serum albumin (BSA). 
Tris-HCI, standard lipids and other chemicals (analytical grade), were 
purchased from Sigma (St. Louis, USA). I-0-hexadecyl t-[‘Hlacetyl- 
swglycero-3-phosphocholine ([‘HIPAF), (IO CiImmol) and l-O- 
[I ’ ,2’-‘H]hexadecyl-2-acetyl-sn-glycero-3-phosp~iocholinc 
([‘H]alkyl-PAF), (59.5 Ci/mmol) were from New England Nuclear 
(Boston, MA), and solvcnrs (analytical grade) were from Fluka 
(Switzerland). [‘HJPAF or [‘Hjalkyl-PAF was dissolved in a solution 
of BSA in 10 mM Tris-HCI, 1 mg/ml, pH 7.4 (BSA/Tris-HCI). Egg 
phosphatidylcholinc was prepared from egg yolk after total lipid ex- 
traction by t/w Bligh and Dyer method [16] followed by TLC with 
chloroform/methanol/water (65:35:6, by volume) as a solvent 
system. Lipid phosphorous was determined using rhc method of 
Unrtlctt 1171, as modified by Marinctti [IS]. 
2.2. Clllfftrc cotrdi/iom attd cell fmcliortaliori 
% /qWjormis slrnin W was grown axcnically at 25°C in a culture 
medium consistiny of 2% (w/v) protcosc-pcptonc. 0,50/o (w/v) 
I>( + )glucosc and 0.2% (w/v) yeast extract. Cells wcrc fractionated 
into pclliclcs, mitochondria, microsomcs nnd cytosol at 4OC csscntial- 
Ip according to the proccdurc of Nozaw and Thompson [ 191 with the 
fallowing cxccptions. The fractionation buffer consisted of 0.25 M 
aucrosc and IO mM ‘I’ria-HCI, pH 7.4. and cells wcrc homogcnizcd by 
nilrbj:cn <nvitaticw using a prcssurc of 40 bar nftcr I min cquilibra- 
lion. Light micfi~scopic obscrvatinn indicated lhot almost all cells 
wrc dirrurtcd by this proccdurc. Total protein concentration in each 
fraction was d~wntlncd by the method of Lowry et al. (tO]. All frac- 
ti0iis wcrc slarcd In amall allquots ill u 2O’C. PAF-AH activity wits 
stable for tll Icast I iiiontli under thcas ronditians, 
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Fig. 1. PAF-AH activity in homogenate and various cell fractions of 
7. py~i/ortnis. Incubations were performed with 124 pg of cell frac- 
tion protein and 72 nM [‘H]PAF at 37%. pH 7.4. Values represent 
the mean + SD for 4 diiferenr cell preparations. 
2.3, Etrzytne asa)’ 
PAF-AH activity was determined by the trichloroacetic acid (TCA) 
precipitation method [21,22], using 13H]PAF as a substrate and the 
various cell fractions suspended in 10 mM Tris-HCI, pH 7.4, as the 
source of the enzyme. For the routine assay, 0.5 ml of [3H]PAF solu- 
tion in BSA/Tris-HCI, was incubated in a polypropylene tube with an 
equal volume of each cell fraction suspension, at 37°C. The final BSA 
and [3H]PAF concentrations in the reaction mixture were 0.5 ma/ml 
and 72 nM respeclively while rhe final cell fraction protein concentra- 
tion was 125 &ml, unless otherwise indicated. Aliquots of 50 pl of 
the reaction mixture were taken at 1 min time intervals up 10 IO min 
and mixed with JO ~1 of 20% TCA solution in microcentrifuge tubes 
at 4%. The mixture was allowed to stand for 15 min at 4°C and rhe 
denatured protein was separated bycentrifugation for 2 min in an Ep- 
pendorf microcentrifuge. 50 ~1 of the supernatant were mixed with 5 
ml of the scintillation fluid (Ready Protein cocktail, Beckman, Fuller- 
ton, CA) and the radioactivity determined in a liquid scintillation 
counter (Tri-Carb 3255, Packard). The [‘H] released in the supcrna- 
tant was identified as [‘Hjacetic acid by the method of Blank et al. [6]. 
Moreover, when [‘Hlalkyl-PAF was used as a substrate, the [‘HI 
found in the supernatant after incubation for 10 min with the 
microsomal fraction, was less than 0.2% of total added [‘Hlalkyl- 
PAF. The control values of the released [3H]acetic acid were obtained 
by mixing 25 gl from the 13H]PAF solution and 25 cl from the ccl] 
fraction suspension with 50~1 of 20% TCA in a microcentrifuge tube 
at 4% The [3H] found in the supernatant after the centrifugation 
(tritiated acetate) was less than 2.5% of total added [‘HIPAF. The 
detection limit of this method is 0.3 pmol.mg.min. 
3. RESULTS 
PAF-AH activity was determined in all cell fractions 
and cell homogenate. As shown in Fig. 1, PAF-AH ac- 
tivity is mainly distributed in the microsomal fraction 
(enzymatic activity, 28.3 + 2.3 pmols*mg*min, 76.5% 
of total). Much lower activity is present in mitochon- 
dria (7.1 & 1.2 pmols*mg*min, 19.2% of total) while 
the pellicle and cytosolic fractions are almost inactive 
(0.940.3 pmols*mg.min and 0.7kO.4 pmols.mg*min 
respectively). PAF-AH activity in all fractions was not 
markedly altered in the presence of 10 mM CaCl2 or 10 
mM KzEDTA but was completely and irreversibly in- 
hibited after incubation of microsomes with 2 mM 
PMSF for 1 h at 37OC (Table I). Further studies with 
this enzyme were performed using the microsomal frac- 
tion. PAF-AH activity in this fraction was linear with 
protein concentration up to 2.50 pg/ml (range of protein 
concentration tested, SO-1000 p&/ml) and with the time 
of incubation up to at least 10 min. The activity profile 
of the enzyme as a function of pH, showed a broad pH 
optimum ranging between 7.4 and 8 (Fig. 2). PAF-AH 
activity was slightly decreased (about 20%) when the 
temperature of incubation was 25”C, conditions under 
which T. pyriformis is normally grown, but was com- 
pletely and irreversibly inhibited after incubation of 
microsomes with 10 mM DFP for 30 min at 37°C (Table 
I). Treatment of microsomes with 1 N HCI, pH 3.5 for 
1 h at 37”C, followed by pH adjustment to 7.4 with 1 
N NaOH, resulted also in a complete loss of the enzyme 
Table I 
Effect of various compounds on T. p_vtjJortnis microsomal PAF-AH activity 
Compound added Concentration % of control [3H]acetate released 
None, 37°C lOOh 
None, 25°C 79+5 
Ca2+ 10 mM 68+-g’ 
EDTA IO mM 11322’ 
DFP 10 mM 0 
PMSF 2 mhl OC 
I N HCI 0 
Ethanol 5 fil in I ml react. mkt. 92~~2 
Egg phosphatidylcholine’ 64 nM 95*4 
I, 640 nhl E3tI 
lncubationsw~~erformcdwith 125,rgof microsonial protein and72 nM [‘H]PAFal pH 7.4: 
‘5 ~1 of the egg phosphatidylcl~oliIle solutions in ethanol wcrc added to I ml of chc rcnclion 
mixture. 
“Control activity in thcsc cxpcrimcnk was 265 l~mols~my*min. 
%milar results wcrc obtained when other cell fractions or ccl1 homogcnatc wcrc used as the 
source of rhe cnaymc. 
Vnlucs rcprcrcnr thc mcim f SD for 4 diffcrctrt nilsrosoinnl prcparatioar. 
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Fig. 2. pH-activity profile of T. pyr~ortnis microsomal PAF-AH. In- 
cubations were performed with 125 11g of microsomai protein and 72 
nM r3H]PAF at 37”C, pH 7.4. Values represent the mean *SD for 
4 different microsomal preparations. 
0.0 0.5 1.0 
lI[3H]PAF Y 107 M-l 
1.5 
Fig. 3. Lineweaver-Burke double-reciprocal plot of T. pyrifomis 
microsomal PAF-AH. Each point represenK the mean valce of 
duplicate experiments. 
activity (Table I). Finally, this microsomal PAF-AH ac- 
tivity was not affected or was slightly inhibited when 5 
pi of egg yolk phosphatidylcholine solution in ethanol 
were added to the reaction mixture in final concentra- 
tion of 64 nM or 640 nM respectively (Table I). Kinetic 
,J. :; depicted in the Lineweaver-Burke double reci- 
proca! plot sh\>wed that this microsomal hydroIase has 
apparent K,, *:nd Vnrax values of 1.56 FM and 373 
pmols *mg*min respectively (Fig. 3). 
4. DISCUSSION 
T. p_yriforttris is considered to be a favorable organ- 
ism for studying membrane structure, function and 
metabolism within the cukariotic cell [23]. The micro- 
somal fraction of this protozoan plays an important 
role in the phospholipid metabolism and a series of dif- 
fcrcnt enzymatic activities has been rcportcd in th., 
subcellular fraction, Some of these are: an alkytglycerol 
monooxygenase that catalyzes the cleavage of the ether 
bond in alkylglycerols [24,25]; a direct phospholipid 
desaturation system that catalyzes the conversion of 
oleoylphosphatidylcholine to linoleoylphosphatidy1- 
choline [26]; and various acyltransferase activities that 
catalyze the acylation of glycerophosphate, monoacyl- 
glycerophosphate and I-acylglycerophosphocholine 
t271. 
Our study provides evidence for the existence in T. 
pyrformis cells of an acylhydrolase activity capable of 
hydrolizing the sn-2 acetyl moiety of the PAF molecule. 
It is mainly distributed in microsomes and has proper- 
ties similar to those of mammalian PAF-AH, an en- 
zyme totally different to the typical PLAz [6-l 11. This 
acylhydrolase activity is acid-labile, Ca’+-independent 
and is completely inhibited by DFP and PMSF. Also it 
seems to be specific for phosphatidates having sn-2 
short chain acyl groups since egg yolk phosphatidyI- 
choline (long chain diacyl type) fails to inhibit PAF 
hydrolysis. This inhibitory study further supports the 
premise that this acylhydrolase activity differs from the 
typical PLAz that utilizes long chain diacylphospho- 
lipids as substrates. This observation is in accordance 
with the results of other investigators who reported the 
absence of any PLA2 activity capable of hydrolizing 
phosphatidylcholine or phosphatidylethanolamine 
(long chain diacyl types) in the microsomal fraction of 
T. pyriformis 1281. 
The distribution of T. pyrifortnis PAF-AH activity, 
mainly in microsomes, is in contrast o the distribution 
of PAF-AH in mammalian ceIIs, which is mainty found 
in the cytosolic fraction [6]. On the other hand, the pro- 
found hydrophobicity of the protozoan PAF-AH 
resembles that of the plasma PAF-AN which is assoc- 
iated with lipoproteins [11], Also, the properties of T, 
pyrifurmis PAF-AH activity seem to be similar to the 
short chain specific microsomal acylhydrolase reported 
by Wykle and Schremmer in Fischer R-3259 sarcoma 
cells [29]. 
The existence of a PAF-AH activity in the protozoan 
cells further supports our previous observation that the 
first step of the metabolism of exogenous PAF by T. 
pyriformis is a rapid deacetylation reaction. Moreover, 
the enzyme distribution in the internal cell compart- 
ments and the absence from the pellicle fraction, could 
explain the small unmetabolized portion of the ex- 
ogenous PAF that remains even after 1 h incubation 
with T, pyriformis cells [ 151. 
This is the first report of the existence of a PAF-AH 
activity in a non-mammalian cell, It is also the first 
study that provides evidence for the existence of a short 
chain specific acylhydrolase in T. pyrifortnis cells. The 
biological role of this acylhydrolase could be the regula- 
tion of the endogenous PAF levels in this protozoan. 
The enzyme purification as well as the substrate 
specificity arc in further investigation i  our laboratory. 
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